Picture of BNB Plus logo

BNBX BNB Plus Share Price

0.000.00%
us flag iconLast trade - 00:00
FinancialsSpeculativeMicro CapValue Trap

Momentum

Relative Strength (%)
1m-6.2%
3m-67.89%
6m-82.57%
1yr-97.84%
Volume Change (%)
10d/3m-53.07%
Price vs... (%)
52w High-97.77%
50d MA-28.75%
200d MA-76.38%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-172.3%
Return on Equity-444.72%
Operating Margin-1552.25%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Sep 202630th Sep 2027
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2026 / 2027

Blurred out image of BNB Plus EPS forecast chart

Profile Summary

BNB Plus Corp., formerly Applied DNA Sciences, Inc., is a digital asset treasury (DAT) company that has adopted BNB, the native cryptocurrency of the Binance blockchain ecosystem, as its primary reserve asset. Its segments include digital asset treasury, therapeutic deoxyribonucleic acid (DNA) production services, DNA tagging and security products and services. Its digital asset treasury segment is engaged in managing digital assets. Its therapeutic DNA production services segment is engaged in nucleic-acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP and LineaIVT. Its DNA tagging and security products and services segment is engaged in the manufacture and detection of DNA for industrial supply chains and security services. Its subsidiary LineaRx, Inc., is engaged in commercializing nucleic acid production solutions for the biopharmaceutical and diagnostics markets.

Directors

Last Annual
September 30th, 2025
Last Interim
December 31st, 2025
Incorporated
December 17th, 2008
Public Since
August 24th, 2001
No. of Shareholders
408
No. of Employees
26
Sector
Investment Banking & Investment Services
Industry
Financials
Exchange
us flag iconNASDAQ Capital Market
Shares in Issue
5,667,469

BNBX Share Price Performance

Upcoming Events for BNBX

BNB Plus Corp Extraordinary Shareholders Meeting

Q2 2026 BNB Plus Corp Earnings Release

BNB Plus Corp Annual Shareholders Meeting

Q3 2026 BNB Plus Corp Earnings Release

Similar to BNBX

Picture of Aether Holdings logo

Aether Holdings

us flag iconNASDAQ Capital Market

Picture of Agora Digital Holdings logo

Agora Digital Holdings

us flag iconNASDAQ Capital Market

Picture of AIOS Tech logo

AIOS Tech

us flag iconNASDAQ Capital Market

Picture of Aixcrypto Holdings logo

Aixcrypto Holdings

us flag iconNASDAQ Capital Market

Picture of AlphaTON Capital logo

AlphaTON Capital

us flag iconNASDAQ Capital Market

FAQ